Doxorubicin-loaded poly(D, L-lactide-co-glycolide)-alendronate nanoparticles for bone cancer treatment: Characterization and in vitro antineoplastic activity

Caterina Fotia, Elisabetta Cenni, Manuela Salerno, Donatella Granchi, Sofia Avnet, Francesco Castelli, Dorotea Micieli, Maria Grazia Sarpietro, Rosario Pignatello, Nicola Baldini

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Original languageEnglish
Title of host publication8th World Biomaterials Congress 2008
Pages1750
Number of pages1
Volume4
Publication statusPublished - 2008
Event8th World Biomaterials Congress 2008, WBC 2008 - Amsterdam, Netherlands
Duration: May 28 2008Jun 1 2008

Other

Other8th World Biomaterials Congress 2008, WBC 2008
CountryNetherlands
CityAmsterdam
Period5/28/086/1/08

ASJC Scopus subject areas

  • Biomaterials

Cite this

Fotia, C., Cenni, E., Salerno, M., Granchi, D., Avnet, S., Castelli, F., Micieli, D., Sarpietro, M. G., Pignatello, R., & Baldini, N. (2008). Doxorubicin-loaded poly(D, L-lactide-co-glycolide)-alendronate nanoparticles for bone cancer treatment: Characterization and in vitro antineoplastic activity. In 8th World Biomaterials Congress 2008 (Vol. 4, pp. 1750)